⌘K
Loading ticker…
Idexx Laboratories Inc · Healthcare · Pharmaceutical Products
As of 2026-06-26, Idexx Laboratories Inc (IDXX) has a 3-month relative strength percentile of 33 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 46. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 2.9%, relative volume 1.96×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
33 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
IDXX is in a stage 4 downtrend, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -1.3% / -12.5%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
IDXX is held by 19 ETFs as of Mar 2026. Top owner: VTI at 0.07% weight, $1.4B notional. Top 3 carry $3.5B.
Top 10 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.07% | $1.4B |
| VOOVanguard S&P 500 ETF | 0.08% | $1.1B |
| VOVanguard Mid-Cap ETF | 0.49% | $966M |
| QQQInvesco QQQ Trust Series I | 0.25% | $942M |
| IVViShares Core S&P 500 ETF | 0.08% | $577M |
| SPYState Street SPDR S&P 500 ETF | 0.08% | $523M |
| VUGVanguard Growth ETF | 0.16% | $521M |
| VOTVanguard Mid-Cap Growth ETF | 1.16% | $340M |
| XLVState Street Health Care Select Sector SPDR ETF | 0.85% | $326M |
| IWFiShares Russell 1000 Growth ETF | 0.16% | $181M |
Showing 10 of 19 ETF owners.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IDXX Jan avg: 2.94% median: 0.59% win: 50% σ: 10.62% n: 4 2022-04-12 → 2026-05-29 | IDXX Feb avg: 2.92% median: 1.03% win: 50% σ: 6.36% n: 4 2022-04-12 → 2026-05-29 | IDXX Mar avg: -4.71% median: -5.03% win: 25% σ: 8.27% n: 4 2022-04-12 → 2026-05-29 | IDXX Apr avg: -4.76% median: -1.58% win: 20% σ: 7.76% n: 5 2022-04-12 → 2026-05-29 | IDXX May avg: 1.08% median: 0.49% win: 60% σ: 10.67% n: 5 2022-04-12 → 2026-05-29 | IDXX Jun avg: 0.03% median: 1.26% win: 50% σ: 8.12% n: 4 2022-04-12 → 2026-05-29 (current) | IDXX Jul avg: 5.40% median: 5.04% win: 50% σ: 7.93% n: 4 2022-04-12 → 2026-05-29 | IDXX Aug avg: 0.37% median: -3.36% win: 50% σ: 14.99% n: 4 2022-04-12 → 2026-05-29 | IDXX Sep avg: -4.27% median: -3.77% win: 25% σ: 8.22% n: 4 2022-04-12 → 2026-05-29 | IDXX Oct avg: -4.79% median: -5.06% win: 25% σ: 12.54% n: 4 2022-04-12 → 2026-05-29 | IDXX Nov avg: 14.56% median: 17.51% win: 100% σ: 7.38% n: 4 2022-04-12 → 2026-05-29 | IDXX Dec avg: 0.71% median: -3.09% win: 25% σ: 12.77% n: 4 2022-04-12 → 2026-05-29 |